Three Republican-led states have challenged the Food and Drug Administration’s (FDA) approval of a generic form of the abortion pill mifepristone earlier this year, arguing the agency’s decision had ignored the “dangerous effects of mifepristone on pregnant women and girls.” The attorney generals for Missouri, Kansas and Idaho earlier this week filed an amended complaint...

See Full Page